Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 May;33(5):227-236.
doi: 10.1089/apc.2019.0021.

CHAMP+ Thailand: Pilot Randomized Control Trial of a Family-Based Psychosocial Intervention for Perinatally HIV-Infected Early Adolescents

Affiliations
Randomized Controlled Trial

CHAMP+ Thailand: Pilot Randomized Control Trial of a Family-Based Psychosocial Intervention for Perinatally HIV-Infected Early Adolescents

Danielle Friedman Nestadt et al. AIDS Patient Care STDS. 2019 May.

Abstract

Within Asia, HIV prevalence is highest in Thailand, including thousands of children and adolescents. Care for children born with HIV [perinatal transmission of HIV (PHIV)] will need to focus on adolescents for the foreseeable future. Thai PHIV adolescents experience significant mental health and psychosocial challenges, including treatment adherence. Yet, few, if any, comprehensive interventions for them exist. CHAMP+, an evidence-based intervention adapted for Thailand, was evaluated with a pilot randomized control trial at four HIV clinics. Eighty-eight dyads of 9- to 14-year-old PHIV young adolescents/caregivers were randomized to CHAMP+ or standard of care (SOC). Eleven cartoon-based sessions were delivered over 6 months. Participants completed baseline, 6-month (postintervention), and 9-month surveys, measuring youth outcomes (e.g., mental health and adherence), contextual factors (e.g., demographics and caregiver factors), and self- and social-regulation factors (e.g., HIV knowledge and youth-caregiver communication). Multi-level modeling to account for clustering within individuals was used to assess longitudinal changes within and between groups. All families randomized to CHAMP+ completed the intervention. Although the study was not statistically powered to detect differences in treatment effects, the CHAMP+ group significantly improved at 6 months in youth mental health and adherence, HIV knowledge, youth-caregiver communication, internalized stigma, and HIV-related social support, with most improvements sustained at 9 months and significantly better improvements than the SOC group on a number of outcomes. High levels of baseline viral suppression highlight the importance of reaching these young PHIV adolescents at a period of lower risk before adherence and other challenges emerge. Designed to be delivered with limited cost/resources, CHAMP+ Thailand holds scale-up potential.

Keywords: HIV+ adolescents; Thailand; adherence; family-based; mental health; psychosocial intervention.

PubMed Disclaimer

Conflict of interest statement

J.A. has received honoraria for participating in advisory meetings for ViiV Healthcare, Gilead, Merck, Roche, and AbbVie.

Figures

<b>FIG. 1.</b>
FIG. 1.
Modified social action theory.

References

    1. UNICEF. The state of the world's children 2017: Statistical tables. Available at: https://data.unicef.org/wp-content/uploads/2018/03/SOWC-2017-statistical... (Last accessed August14, 2018)
    1. UNAIDS. Thailand. Available at: www.unaids.org/en/regionscountries/countries/thailand (Last accessed August14, 2018)
    1. Lolekha R. Elimination of mother-to-child transmission of HIV—Thailand. MMWR Morb Mortal Wkly Rep 2016;65:562–566 - PubMed
    1. Mellins CA, Malee KM. Understanding the mental health of youth living with perinatal HIV infection: Lessons learned and current challenges. J Int AIDS Soc 2013;16:18593 - PMC - PubMed
    1. Bomba M, Nacinovich R, Oggiano S, et al. . Poor health-related quality of life and abnormal psychosocial adjustment in Italian children with perinatal HIV infection receiving highly active antiretroviral treatment. AIDS Care 2010;22:858–865 - PubMed

Publication types

MeSH terms

Substances